Abstract
Head and neck squamous cell carcinomas (HNSCC) are characterized by upregulation of the epidermal growth factor receptor (EGFR), where EGFR serves as a potential therapeutic target. We previously reported that a gastrin-releasing peptide/gastrin-releasing peptide receptor (GRP/GRPR) autocrine growth pathway is activated early in HNSCC carcinogenesis. In the present study, we examined the mechanism of EGFR activation by GRP/GRPR in HNSCC proliferation. In HNSCC cells that express elevated levels of both GRPR and EGFR, we found that GRP induced rapid phosphorylation of EGFR as well as p44/42-MAPK activation. Using several EGFR-specific tyrosine kinase inhibitors and cells derived from EGFR knockout mice, we demonstrated that GRP-induced p44/42-MAPK activation was dependent upon EGFR activation. Further investigation demonstrated that cleavage of transforming growth factor-alpha (TGF-α) by matrix metalloproteinases mediated GRP-induced MAPK activation. In addition, HNSCC proliferation stimulated by GRP was eliminated upon specific inhibition of EGFR or MEK, and GRP failed to stimulate proliferation in EGFR-deficient cells. These results imply that the mitogenic effects of GRP in HNSCC are mediated by extracellular release of TGF-α and require the activation of an EGFR-dependent MEK/MAPK-dependent pathway.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adelsman MA, Huntley BK and Maihle NJ . (1996). J. Virol., 70, 2533–2544.
Akeson M, Sainz E, Mantey SA, Jensen RT and Battey JF . (1997). J. Biol. Chem., 272, 17405–17409.
Alexander RW, Upp Jr JR, Poston GJ, Gupta V, Townsend Jr CM and Thompson JC . (1988). Cancer Res., 48, 1439–1441.
Anastasi A, Erspamer V and Bucci M . (1971). Experientia, 27, 166–167.
Boerner JL, Danielsen A, McManus MJ and Maihle NJ . (2001). J. Biol. Chem., 276, 3691–3695.
Buhl AM, Johnson NL, Dhanasekaran N and Johnson GL . (1995). J. Biol. Chem., 270, 24631–24634.
Carney DN, Cuttitta F, Moody TW and Minna JD . (1987). Cancer Res., 47, 821–825.
Carroll RE, Matkowskyj KA, Tretiakova MS, Battey JF and Benya RV . (2000). Cell Growth Differ., 11, 385–393.
Castagliuolo I, Valenick L, Liu J and Pothoulakis C . (2000). J. Biol. Chem., 275, 26545–26550.
Charlesworth A, Broad S and Rozengurt E . (1996). Oncogene, 12, 1337–1345.
Chaudhry A, Carrasquillo JA, Avis IL, Shuke N, Reynolds JC, Bartholomew R, Larson SM, Cuttitta F, Johnson BE and Mulshine JL . (1999). Clin. Cancer Res., 5, 3385–3393.
Corjay MH, Dobrzanski DJ, Way JM, Viallet J, Shapira H, Worland P, Sausville EA and Battey JF . (1991). J. Biol. Chem., 266, 18771–18779.
Daub H, Wallasch C, Lankenau A, Herrlich A and Ullrich A . (1997). Embo. J., 16, 7032–7044.
Fathi Z, Corjay MH, Shapira H, Wada E, Benya R, Jensen R, Viallet J, Sausville EA and Battey JF . (1993). J. Biol. Chem., 268, 5979–5984.
Feldman RI, Bartholdi MF and Wu JM . (1996). Mol. Pharmacol., 50, 1346–1354.
Grandis JR, Chakraborty A, Melhem MF, Zeng Q and Tweardy DJ . (1997). Oncogene, 15, 409–416.
Gschwind A, Zwick E, Prenzel N, Leserer M and Ullrich A . (2001). Oncogene, 20, 1594–1600.
Halmos G and Schally AV . (1997). Proc. Natl. Acad. Sci. USA, 94, 956–960.
Halmos G, Wittliff JL and Schally AV . (1995). Cancer Res., 55, 280–287.
Heeneman S, Haendeler J, Saito Y, Ishida M and Berk BC . (2000). J. Biol. Chem., 275, 15926–15932.
Hellmich MR, Battey JF and Northup JK . (1997). Proc. Natl. Acad. Sci. USA, 94, 751–756.
Herrlich A, Daub H, Knebel A, Herrlich P, Ullrich A, Schultz G and Gudermann T . (1998). Proc. Natl. Acad. Sci. USA, 95, 8985–8990.
Kelley MJ, Linnoila RI, Avis IL, Georgiadis MS, Cuttitta F, Mulshine JL and Johnson BE . (1997). Chest, 112, 256–261.
Koppan M, Halmos G, Arencibia JM, Lamharzi N and Schally AV . (1998). Cancer, 83, 1335–1343.
Lach EB, Broad S and Rozengurt E . (1995). Cell Growth Differ., 6, 1427–1435.
Lango MN, Dyer KF, Lui VW, Gooding WE, Gubish C, Siegfried JM and Grandis JR . (2002). J. Natl. Cancer Inst., 94, 375–383.
Lebacq-Verheyden AM, Trepel J, Sausville EA and Battey JF . (1990). Handbook of Experimental Pharmacology, Vol. 95/II. Sporn MN and Roberts AB. (eds) Springer-Verlag: Berlin, pp 71–124.
Liebow C, Crean DH, Lee MT, Kamer AR, Mang TS and Schally AV . (1994). Proc. Natl. Acad. Sci. USA, 91, 3804–3808.
Linseman DA, Benjamin CW and Jones DA . (1995). J. Biol. Chem., 270, 12563–12568.
Mitamura T, Higashiyama S, Taniguchi N, Klagsbrun M and Mekada E . (1995). J. Biol. Chem., 270, 1015–1019.
McCole DF, Keely SJ, Coffey RJ, Barrett KE . (2002). Transactivation of the epidermal growth factor receptor in colonic epithelial cells by carbachol requires extracellular release of transforming growth factor-alpha. J Biol Chem, 277 (45), 42603–42612.
Nagakawa O, Murakami K, Yamaura T, Fujiuchi Y, Murata J, Fuse H and Saiki I . (2000). Cancer Lett., 155, 173–179.
Nagakawa O, Ogasawara M, Murata J, Fuse H and Saiki I . (2001). Int. J. Urol., 8, 65–70.
Nagalla SR, Barry BJ, Creswick KC, Eden P, Taylor JT and Spindel ER . (1995). Proc. Natl. Acad. Sci. USA, 92, 6205–6209.
Pansky A, De Weerth A, Fasler-Kan E, Boulay JL, Schulz M, Ketterer S, Selck C, Beglinger C, Von Schrenck T and Hildebrand P . (2000). J. Am. Soc. Nephrol., 11, 1409–1418.
Pinski J, Schally AV, Halmos G, Szepeshazi K, Groot K, O'Byrne K and Cai RZ . (1994). Br. J. Cancer, 70, 886–892.
Plonowski A, Nagy A, Schally AV, Sun B, Groot K and Halmos G . (2000). Int. J. Cancer, 88, 652–657.
Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C and Ullrich A . (1999). Nature, 402, 884–888.
Rao GN, Delafontaine P and Runge MS . (1995). J. Biol. Chem., 270, 27871–27875.
Rounseville MP and Davis TP . (2000). J. Mol. Endocrinol., 25, 121–128.
Rozengurt E . (1986). Science, 234, 161–166.
Rozengurt E and Sinnett-Smith J . (1983). Proc Natl Acad Sci U S A, 80, 2936–2940.
Rubin Grandis J, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD and Tweardy DJ . (1998). J. Natl. Cancer Inst., 90, 824–832.
Santiskulvong C, Sinnett-Smith J and Rozengurt E . (2001). Am. J. Physiol. Cell Physiol., 281, C886–C898.
Sharif TR, Luo W and Sharif M . (1997). Mol. Cell Endocrinol., 130, 119–130.
Shin DM, Donato NJ, Perez-Soler R, Shin HJ, Wu JY, Zhang P, Lawhorn K, Khuri FR, Glisson BS, Myers J, Clayman G, Pfister D, Falcey J, Waksal H, Mendelsohn J and Hong WK . (2001). Clin. Cancer Res., 7, 1204–1213.
Siegfried JM, Gaither Davis A and Gubish CT . (1998). Biology of Lung Cancer, Kane MAaB, PA Jr. (eds) Marcel Dekker, Inc.: New York, pp. 317–336.
Siegfried JM, Krishnamachary N, Gaither Davis A, Gubish C, Hunt JD and Shriver SP . (1999). Pulm. Pharmacol. Ther., 12, 291–302.
Sorenson GD, Bloom SR, Ghatei MA, Del Prete SA, Cate CC and Pettengill OS . (1982). Regul. Pept., 4, 59–66.
Sun B, Halmos G, Schally AV, Wang X and Martinez M . (2000a). Prostate, 42, 295–303.
Sun B, Schally AV and Halmos G . (2000b). Regul. Pept., 90, 77–84.
Szepeshazi K, Schally AV, Halmos G, Lamharzi N, Groot K and Horvath JE . (1997). Proc. Natl. Acad. Sci. USA, 94, 10913–10918.
Venkatakrishnan G, Salgia R and Groopman JE . (2000). J. Biol. Chem., 275, 6868–6875.
Wada E, Way J, Shapira H, Kusano K, Lebacq-Verheyden AM, Coy D, Jensen R and Battery J . (1991). Neuron, 6, 421–430.
Acknowledgements
This work was supported by EDRN grant (U01CA84968) to J R Grandis and J M Siegfried, NCI Lung cancer SPORE grant (P50CA90440 and R01CA79882) to J M Siegfried and Lung SPORE post-doctoral fellowship to V W Y Lui and S M Thomas.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lui, V., Thomas, S., Zhang, Q. et al. Mitogenic effects of gastrin-releasing peptide in head and neck squamous cancer cells are mediated by activation of the epidermal growth factor receptor. Oncogene 22, 6183–6193 (2003). https://doi.org/10.1038/sj.onc.1206720
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1206720
Keywords
This article is cited by
-
Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR
Cell Death & Disease (2022)
-
Precision drugging of the MAPK pathway in head and neck cancer
npj Genomic Medicine (2022)
-
Novel role of gastrin releasing peptide-mediated signaling in the host response to influenza infection
Mucosal Immunology (2019)
-
Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
BMC Cancer (2018)
-
How gastrin-releasing peptide receptor (GRPR) and αvβ3 integrin expression reflect reorganization features of tumors after hyperthermia treatments
Scientific Reports (2017)